Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Savara Inc
(NQ:
SVRA
)
4.370
-0.040 (-0.91%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Savara Inc
< Previous
1
2
3
4
Next >
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
February 28, 2023
From
Savara Inc.
Via
Business Wire
JD.com And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
February 21, 2023
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Savara Announces New Leadership Appointments
February 14, 2023
From
Savara Inc.
Via
Business Wire
Why Shares of Savara Soared This Week
January 27, 2023
The clinical-stage biopharmaceutical company focuses on therapies to treat rare respiratory diseases.
Via
The Motley Fool
Savara Announces New Employment Inducement Grant
January 20, 2023
From
Savara Inc.
Via
Business Wire
$1.2 Million Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Buying
January 04, 2023
The Dow Jones edged lower on the first trading session of 2023. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...
Via
Benzinga
Savara Announces New Employment Inducement Grant
November 22, 2022
From
Savara Inc.
Via
Business Wire
Savara Reports Third Quarter 2022 Financial Results and Provides Business Update
November 10, 2022
From
Savara Inc.
Via
Business Wire
Savara to Participate in Three Upcoming Investor Conferences
November 09, 2022
From
Savara Inc.
Via
Business Wire
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
September 14, 2022
From
Savara Inc.
Via
Business Wire
Savara Presented Data at the European Respiratory Society (ERS) International Congress 2022
September 06, 2022
From
Savara Inc.
Via
Business Wire
Savara to Present at H.C. Wainwright 24th Annual Global Investment Conference
September 01, 2022
From
Savara Inc.
Via
Business Wire
Savara Announces Resignation of Chief Medical Officer
August 26, 2022
From
Savara Inc.
Via
Business Wire
Savara Awarded Promising Innovative Medicine (PIM) Designation in the United Kingdom (UK) for Molgramostim Nebulizer Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
August 25, 2022
From
Savara Inc.
Via
Business Wire
Recap: Savara Q2 Earnings
August 11, 2022
Savara (NASDAQ:SVRA) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Savara reported in-line EPS of...
Via
Benzinga
Savara Reports Second Quarter 2022 Financial Results and Provides Business Update
August 11, 2022
From
Savara Inc.
Via
Business Wire
Savara Announces Acceptance of Three Abstracts at the European Respiratory Society (ERS) International Congress 2022
July 11, 2022
From
Savara Inc.
Via
Business Wire
Savara Awarded Innovation Passport in United Kingdom (UK) for Molgramostim Nebulizer Solution (Molgramostim), a Novel Investigational Inhaled Biologic
June 16, 2022
From
Savara Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
June 13, 2022
Gainers
Via
Benzinga
Savara to Present at Jefferies Healthcare Conference
June 01, 2022
From
Savara Inc.
Via
Business Wire
Savara to Present at H.C. Wainwright Global Investment Conference
May 17, 2022
From
Savara Inc.
Via
Business Wire
Savara: Q1 Earnings Insights
May 11, 2022
Savara (NASDAQ:SVRA) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Savara beat estimated earnings by...
Via
Benzinga
Savara Reports First Quarter 2022 Financial Results and Provides Business Update
May 11, 2022
From
Savara Inc.
Via
Business Wire
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
April 26, 2022
From
Savara Inc.
Via
Business Wire
The Daily Biotech Pulse: WHO Endorses Pfizer's Oral COVID Therapy, Vallon Pharma Surges On Strategic Review, Novavax Starts Dosing In Adolescents COVID Booster Trial
April 22, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
Savara Announces Debt Refinancing of $26.5M Credit Facility With Silicon Valley Bank
April 22, 2022
From
Savara Inc.
Via
Business Wire
Savara Reports Fourth Quarter / Year-End 2021 Financial Results and Provides Business Update
March 30, 2022
From
Savara Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
March 18, 2022
Gainers
Via
Benzinga
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
March 16, 2022
From
Savara Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
January 27, 2022
Gainers Avidity Biosciences (NASDAQ:RNA) s...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.